All Stories

  1. In Vitro Susceptibility and Molecular Docking of Echinocandins Against Clinical Dermatophyte Isolates: Implications for Resistant Dermatophytosis
  2. Isolation of a multidrug-resistant Candida auris Clade V from an asymptomatic acute myeloid leukemia patient in the intensive care unit
  3. Oral Cryptococcosis due to Naganishia diffluens in a Patient With Thalassemia: A Case Report and a Literature Review
  4. Dermatophytosis in Iran: a sharp increase in cases caused by Trichophyton mentagrophytes var. indotineae
  5. Antifungal Efficacy of Luliconazole-Loaded Nanostructured Lipid-Carrier Gel in an Animal Model of Dermatophytosis
  6. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  7. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  8. Molecular epidemiology of dermatophytosis in Golestan, Iran: A cross-sectional study
  9. High Prevalence of Azole‐Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?
  10. Multi‐state evaluation of Candida infections in burn patients
  11. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  12. Synthesis, computational study, and antileishmanial and antifungal evaluation of phenoxyacetophenone hydrazones bearing a 4-arylthiazole moiety
  13. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  14. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  15. Caspian Sea Mycosands: The Variety and Abundance of Medically Important Fungi in Beach Sand and Water
  16. Confirmation of fifth Candida auris clade by whole genome sequencing
  17. A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of Aspergillus from Iran
  18. Five Years Surveillance Study of Clinical and Environmental Triazole‐Resistant Aspergillus fumigatus Isolates in Iran
  19. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North‐Western Iran
  20. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis
  21. Development of RFLP method for rapid differentiation of Aspergillus flavus and Aspergillus oryzae, two species with high importance in clinical and food microbiology
  22. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  23. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole
  24. Differentiation of Aspergillus flavus from Aspergillus oryzae Targeting the cyp51A Gene
  25. In vitro antifungal activity of Thymus vulgaris essential oil nanoemulsion
  26. Diversity of Geophilic Dermatophytes Species in the Soils of Iran; The Significant Preponderance of Nannizzia fulva
  27. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  28. Galactomannan detection in bronchoalveolar lavage fluids: A diagnostic approach for fungus ball in patients with pulmonary tuberculosis?
  29. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria
  30. Relationship between spirometry results and colonisation of Aspergillus species in allergic asthma
  31. Molecular epidemiology of Tinea gladiatorum in contact sports in northern Iran
  32. <p>Emergence of Terbinafine Resistant <em>Trichophyton mentagrophytes</em> in Iran, Harboring Mutations in the Squalene Epoxidase (<em>SQLE</em>) Gene</p>
  33. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  34. Indole-derived chalcones as anti-dermatophyte agents: In vitro evaluation and in silico study
  35. Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
  36. Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complex
  37. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources
  38. A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?
  39. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  40. Discrimination of Aspergillus flavus from Aspergillus oryzae by matrix‐assisted laser desorption/ionization time‐of‐flight (MALDI‐TOF) mass‐spectrometry
  41. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations
  42. Potential Fifth Clade ofCandida auris,Iran, 2018
  43. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-offlight mass spectrometry
  44. Novel Point Mutations in cyp51A and cyp51B Genes Associated with Itraconazole and Posaconazole Resistance in Aspergillus clavatus Isolates
  45. Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex
  46. Candida auris otomycosis in Iran and review of recent literature
  47. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review
  48. Prevalence of specific immunoglobulin E and G against Aspergillus fumigatus in patients with asthma
  49. Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review
  50. Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
  51. In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis
  52. Molecular identification and antifungal susceptibility testing of Candida species isolated from dental plaques
  53. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies
  54. Potent Activities of Luliconazole, Lanoconazole, and Eight Comparators against Molecularly Characterized Fusarium Species
  55. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
  56. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry
  57. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran
  58. Invasive forms of Candida and Aspergillus in sputum samples of pulmonary tuberculosis patients attending the tuberculosis reference laboratory in Ghaemshahr, Northern Iran: An analysis of samples collected during the past 10years
  59. Characterization of clinically important dermatophytes in North of Iran using PCR-RFLP on ITS region
  60. Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays
  61. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains
  62. In vitroactivity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates: Table 1.
  63. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma
  64. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran
  65. The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs
  66. PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus
  67. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species
  68. History of treated pulmonary tuberculosis will also be an underlying symptom of opportunistic aspergillosis by Aspergillus flavus: A case report
  69. Coexistence of opportunistic mycosis and mycobacterium tuberculosis in patients attending the Central Tuberculosis Reference Laboratory of Ghaemshahr city, Iran
  70. Restriction Analysis of β-Tubulin Gene for Differentiation of the Common Pathogenic Dermatophytes
  71. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma
  72. Microsporum fulvum, an Ignored Pathogenic Dermatophyte: A New Clinical Isolation from Iran